Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.

Kuroda T, Nagata S, Takizawa Y, Tamura N, Kusano K, Mizobe F, Hariu K.

Vet J. 2013 Aug;197(2):433-7. doi: 10.1016/j.tvjl.2013.02.003. Epub 2013 Mar 11.

PMID:
23489843
2.

Pharmacokinetics and pharmacodynamics of clemastine in healthy horses.

Törneke K, Ingvast-Larsson C, Pettersson K, Bergvall K, Hedeland M, Bondesson U, Broström H.

J Vet Pharmacol Ther. 2003 Apr;26(2):151-7.

PMID:
12667185
3.

Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.

Olsén L, Ingvast-Larsson C, Larsson P, Broström H, Bondesson U, Sundqvist M, Tjälve H.

J Vet Pharmacol Ther. 2006 Apr;29(2):129-35.

PMID:
16515667
4.

Cetirizine in horses: pharmacokinetics and pharmacodynamics following repeated oral administration.

Olsén L, Bondesson U, Broström H, Tjälve H, Ingvast-Larsson C.

Vet J. 2008 Aug;177(2):242-9. Epub 2007 Jun 19.

PMID:
17581764
5.

Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.

Bizikova P, Papich MG, Olivry T.

Vet Dermatol. 2008 Dec;19(6):348-57. doi: 10.1111/j.1365-3164.2008.00697.x. Epub 2008 Oct 11.

PMID:
18980631
6.

Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.

Olsén L, Ingvast-Larsson C, Bondesson U, Broström H, Tjälve H, Larsson P.

J Vet Pharmacol Ther. 2007 Jun;30(3):194-200.

PMID:
17472650
7.

Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.

Puigdemont A, Queralt M, Jansat JM, Martinez-Tobed A.

J Pharm Pharmacol. 1994 Jul;46(7):596-9.

PMID:
7996390
8.
9.

The comparative pharmacokinetics of H1-receptor antagonists.

Simons FE, Simons KJ, Chung M, Yeh J.

Ann Allergy. 1987 Dec;59(6 Pt 2):20-4. Erratum in: Ann Allergy 1988 Jun;60(6):540.

PMID:
2892445
10.

Systemic bioavailability of nasally applied chlorphenamine maleate (0.4% nasal spray) relative to tablets administered perorally.

Van Toor BS, Buchwald A, Stengele E, Trenk D, Gercek C, de Mey CM.

Int J Clin Pharmacol Ther. 2001 Apr;39(4):173-8.

PMID:
11332874
11.

Clinical pharmacology of clemastine in healthy dogs.

Hansson H, Bergvall K, Bondesson U, Hedeland M, Törneke K.

Vet Dermatol. 2004 Jun;15(3):152-8.

PMID:
15214951
12.

Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.

Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR.

Am J Vet Res. 2012 Feb;73(2):290-5. doi: 10.2460/ajvr.73.2.290.

PMID:
22280392
13.

Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidine.

Koch KM, O'Connor-Semmes RL, Davis IM, Yin Y.

J Pharm Sci. 1998 Sep;87(9):1097-100.

PMID:
9724561
14.
15.

Clinical pharmacokinetics of mizolastine.

Lebrun-Vignes B, Diquet B, Chosidow O.

Clin Pharmacokinet. 2001;40(7):501-7. Review.

PMID:
11510627
16.

Pharmacokinetics of acetazolimide after intravenous and oral administration in horses.

Alberts MK, Clarke CR, MacAllister CG, Homer LM.

Am J Vet Res. 2000 Aug;61(8):965-8.

PMID:
10951991
17.
18.

Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses.

Fernández-Varón E, Cárceles CM, Marín P, Martos N, Escudero E, Ayala I.

Am J Vet Res. 2006 Jun;67(6):1076-81.

PMID:
16740105
19.

Formulation and stability study of chlorpheniramine maleate nasal gel.

Soliman II, Soliman NA, Abdou EM.

Pharm Dev Technol. 2010 Sep-Oct;15(5):484-91. doi: 10.3109/10837450903286545.

PMID:
20735301
20.

The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine.

Yasuda SU, Zannikos P, Young AE, Fried KM, Wainer IW, Woosley RL.

Br J Clin Pharmacol. 2002 May;53(5):519-25.

Supplemental Content

Support Center